Healthcare as Collaboration: Using Participatory Medicine to Cure What Ails Healthcare (Recorded at Pri-Med South)
For four decades, leading physicians have called patients the most under-used resource in healthcare, a sentiment amplified by statements like "Nothing about me without me." But slogans alone don’t cause change, and the time has come to teach clinicians (and patients/caregivers) to evolve healthcare in the internet age and to seek the evidence, rationale, and theoretical basis for these practices. While many patients are not yet "e-patients" (empowered and engaged), new care models are emerging and real. When new methods are understood and developed, the workload can be rebalanced, and the results can be more fulfilling for all. This unconventional keynote will be shared, fittingly, by the best-known exemplars of this new model: stage IV cancer survivor "e-Patient Dave" deBronkart and his physician, Dr. Danny Sands. They are two of the co-founders of the Society for Participatory Medicine and co-authors of "Let Patients Help: A Patient Engagement Handbook." Participants will learn about the transformative and potentially disruptive movement of participatory medicine, and they will leave informed -- even empowered -- to take effective new actions on behalf of their patients.
Biotricity, Advisory Board; Biotricity, Ownership Interest; Conversa Health, Consultant; Conversa Health, Ownership Interest; Health Vector, Advisory Board; Health Vector, Ownership Interest; Medisafe, Consultant; Wego Health, Advisory Board; Wego Health, Ownership Interest
Non-faculty contributors and others involved in the planning, development, and editing/review of the content have no relevant financial relationships to disclose.
pmiCME is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
pmiCME designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The opinions, ideas, and recommendations expressed in this educational activity are those of the faculty only and are not necessarily endorsed by, nor do they necessarily reflect, those of their affiliated institutions, pmiCME, pmiCME Advisory Boards and Consultants, DBC Pri-Med, LLC.
Clinical judgment must guide each clinician in weighing the possible risks, benefits, or contraindications of any diagnostics, interventions or treatments discussed. Clinicians should review manufacturers’ product information and consider these with the recommendations of other authorities when applying the assessment and/or clinical management strategies discussed in this activity to the care of their patients.
pmiCME educational activities are developed and conducted in accordance with the ACCME's Essential Areas and Policies. It is the mission of pmiCME to develop and present educational activities that are timely, fair-balanced, scientifically rigorous, and that serve to improve patient outcomes. To that end, we welcome your comments about how to better serve your needs.
pmiCME Accredited Provider
Pri-Med programs are owned and operated by DBC Pri-Med, LLC, a division of Diversified Communications, Inc. pmiCME, the accredited division of Pri-Med, is accredited with commendation by the ACCME and approved as a provider of continuing education by the AANP. pmiCME is the accredited provider for this activity.
Disclosures and Conflict of Interest
pmiCME requires all individuals in a position to influence educational content for pmiCME-certified CME/CE activities to disclose relevant personal financial relationships with commercial interests prior to contributing to its educational activities. pmiCME assesses disclosed relationships and follows a defined process to resolve real or implied conflicts to ensure, to the best of its ability, that all educational content is free of commercial bias. Financial disclosures are listed in the activity syllabus and will also be printed on the slides and announced at the start of each presentation.
Discussion of Off-Label Uses and Investigational Products
During the course of their presentations, the faculty may mention uses of products that have not been approved in the United States for the indication(s) being discussed. All presenters are instructed to notify participants when they are discussing unapproved uses or investigational agents. In addition, specific slides will include notation of the off-label use or investigational agent being discussed. Views presented related to unapproved uses of products are solely those of the presenter(s) and are not endorsed by pmiCME or DBC Pri-Med, LLC.
Questions? If you have questions about this activity, please email email@example.com or call (877) 477-4633.